171 related articles for article (PubMed ID: 10447330)
1. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8.
Engel A; Steinbach G; Kern P; Kern WV
Scand J Infect Dis; 1999; 31(2):185-9. PubMed ID: 10447330
[TBL] [Abstract][Full Text] [Related]
2. Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.
Koivula I; Hämäläinen S; Jantunen E; Pulkki K; Kuittinen T; Nousiainen T; Juutilainen A
Scand J Infect Dis; 2011 Jul; 43(6-7):471-8. PubMed ID: 21299364
[TBL] [Abstract][Full Text] [Related]
3. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
[TBL] [Abstract][Full Text] [Related]
4. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever.
Chirouze C; Schuhmacher H; Rabaud C; Gil H; Khayat N; Estavoyer JM; May T; Hoen B
Clin Infect Dis; 2002 Jul; 35(2):156-61. PubMed ID: 12087521
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.
Fleischhack G; Kambeck I; Cipic D; Hasan C; Bode U
Br J Haematol; 2000 Dec; 111(4):1093-102. PubMed ID: 11167745
[TBL] [Abstract][Full Text] [Related]
6. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia.
Persson L; Engervall P; Magnuson A; Vikerfors T; Söderquist B; Hansson LO; Tidefelt U
Scand J Infect Dis; 2004; 36(5):365-71. PubMed ID: 15287382
[TBL] [Abstract][Full Text] [Related]
7. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.
Engel A; Mack E; Kern P; Kern WV
Infection; 1998; 26(4):213-21. PubMed ID: 9717678
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients.
Kallio R; Surcel HM; Bloigu A; Syrjälä H
Eur J Cancer; 2000 May; 36(7):889-94. PubMed ID: 10785594
[TBL] [Abstract][Full Text] [Related]
9. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.
Erten N; Genc S; Besisik SK; Saka B; Karan MA; Tascioglu C
J Chin Med Assoc; 2004 May; 67(5):217-21. PubMed ID: 15357107
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 as an early diagnostic marker for bacterial sepsis in patients with liver cirrhosis.
Lin S; Huang Z; Wang M; Weng Z; Zeng D; Zhang Y; Zhu Y; Jiang J
J Crit Care; 2015 Aug; 30(4):732-8. PubMed ID: 25891645
[TBL] [Abstract][Full Text] [Related]
11. Serial procalcitonin levels to detect bacteremia in febrile neutropenia.
Reitman AJ; Pisk RM; Gates JV; Ozeran JD
Clin Pediatr (Phila); 2012 Dec; 51(12):1175-83. PubMed ID: 23034950
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.
Prat C; Sancho JM; Dominguez J; Xicoy B; Gimenez M; Ferra C; Blanco S; Lacoma A; Ribera JM; Ausina V
Leuk Lymphoma; 2008 Sep; 49(9):1752-61. PubMed ID: 18661397
[TBL] [Abstract][Full Text] [Related]
13. Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study.
Giamarellou H; Giamarellos-Bourboulis EJ; Repoussis P; Galani L; Anagnostopoulos N; Grecka P; Lubos D; Aoun M; Athanassiou K; Bouza E; Devigili E; Krçmery V; Menichetti F; Panaretou E; Papageorgiou E; Plachouras D
Clin Microbiol Infect; 2004 Jul; 10(7):628-33. PubMed ID: 15214875
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of procalcitonin for excluding bloodstream infection: results of a retrospective study and utility of a rapid, quantitative test for procalcitonin.
Wang H; Yin F; Shen DX; Zhang YJ; Luo YP; Liu CJ; Wang KF; Zhou G; Ye LY; Chen G; Wang XN
J Int Med Res; 2013 Oct; 41(5):1671-81. PubMed ID: 24065454
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation.
Ortega M; Rovira M; Filella X; Almela M; Puig de la Bellacasa J; Carreras E; Mensa J
Br J Haematol; 2004 Aug; 126(3):372-6. PubMed ID: 15257709
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U
Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721
[TBL] [Abstract][Full Text] [Related]
17. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia.
Jimeno A; García-Velasco A; del Val O; González-Billalabeitia E; Hernando S; Hernández R; Sánchez-Muñoz A; López-Martín A; Durán I; Robles L; Cortés-Funes H; Paz-Ares L
Cancer; 2004 Jun; 100(11):2462-9. PubMed ID: 15160353
[TBL] [Abstract][Full Text] [Related]
18. IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients.
Vänskä M; Koivula I; Jantunen E; Hämäläinen S; Purhonen AK; Pulkki K; Juutilainen A
Cytokine; 2012 Dec; 60(3):787-92. PubMed ID: 22902948
[TBL] [Abstract][Full Text] [Related]
19. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia.
Giamarellos-Bourboulis EJ; Grecka P; Poulakou G; Anargyrou K; Katsilambros N; Giamarellou H
Clin Infect Dis; 2001 Jun; 32(12):1718-25. PubMed ID: 11360214
[TBL] [Abstract][Full Text] [Related]
20. The role of CRP, PCT, IL-6 and presepsin in early diagnosis of bacterial infectious complications in paediatric haemato-oncological patients.
Plesko M; Suvada J; Makohusova M; Waczulikova I; Behulova D; Vasilenkova A; Vargova M; Stecova A; Kaiserova E; Kolenova A
Neoplasma; 2016; 63(5):752-60. PubMed ID: 27468879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
